A detailed history of Arlington Trust CO LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Arlington Trust CO LLC holds 2,701 shares of LLY stock, worth $2.54 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
2,701
Previous 2,785 3.02%
Holding current value
$2.54 Million
Previous $1.62 Million 29.45%
% of portfolio
0.54%
Previous 0.46%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $49,744 - $66,551
-84 Reduced 3.02%
2,701 $2.1 Million
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $1.22 Million - $1.44 Million
2,328 Added 509.41%
2,785 $1.62 Million
Q3 2023

Oct 24, 2023

BUY
$434.7 - $599.3 $198,657 - $273,880
457 New
457 $245,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $893B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Arlington Trust CO LLC Portfolio

Follow Arlington Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Trust CO LLC with notifications on news.